Screening for hepatocellular carcinoma by Egyptian physicians

Table 5 Relation between hospital setting and knowledge of hepatocellular carcinoma epidemiology

	Type of hospital				P value
	University		MOH
	n	%	n	%
People who should undergo HCC surveillance
Chronic hepatitis B, C and liver cirrhosis	79	83	54	91	0.141
Positive family history	44	46	10	17	0.000a
Everyone	17	18	5	8	0.104
Reduction of deaths from HCC by screening					0.749
< 30%	22	23	15	25
≥ 30%	73	77	44	75
Risk factors for progression of the disease
Age	43	45	20	34	0.163
Regular alcohol consumption	47	49	24	41	0.287
Gender	37	39	13	22	0.029a
Obesity, DM	37	39	18	30	0.288
HCV genotype	55	58	31	52	0.516
HBV-HCV co-infection	50	53	28	47	0.532
Leading cause of HCC					0.011a
HCV	82	86	41	70
HBV	13	14	18	30
Cause of death of HCC patients					0.493
Cancer	43	45	24	41
Liver failure	34	36	19	32
GI or variceal bleeding	18	19	16	27

^aP < 0.05 considered statistically significant. MOH: Ministry of Health; HCC: Hepatocellular carcinoma; HBV: Hepatitis B virus; HCV: Hepatitis C virus.